Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & New Loan Facility

18 Aug 2021 07:00

RNS Number : 9585I
Falanx Group Limited
18 August 2021
 

18 August 2021

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Trading Update & New Loan Facility

Falanx Group Limited (FLX.L), the AIM listed provider of cyber security and strategic intelligence services, is pleased to announce a trading update for the year ended 31 March 2021 and a new loan facility to support further investment.

 

· Revenues of c£5.2m for the year ended 31 March 2021 (2020: £5.8m), slight decline due to previously reported COVID-19 delays in the first half of the period

· Anticipated reduced loss at an adjusted EBITDA level for the year ended 31 March 2021 due to tight cost control

· Post-period, a new loan facility to support organic investment and potential earnings enhancing acquisition opportunities

· Cyber Security division traded strongly in the second half of the period and this encouraging sales performance has continued into the first four months of the current financial year

· Contract wins and increased industry recognition in the Assynt strategic intelligence division

 

Results for the year ended 31 March 2021

 

The Group recorded revenues of c£5.2m (2020: £5.8m), with the decline resulting from the impact of COVID-19 related delays (mainly in the Cyber Security division) which affected the first half of the financial year as highlighted in its interim results. In the second half of the financial year, the Cyber division experienced a greater intake of customer orders which were ahead of the pre-COVID-19 period. The utilisation of the Cyber Security professional services team significantly increased which supported an improvement in gross margin. A tight grip was maintained on operating costs, which helped the Group achieve a reduced loss at an adjusted EBITDA level compared with the year ended 31 March 2020.

 

Cash balances at 31 March 2021 were £0.55m (2020: £0.07m) and the Group had a normal working capital position with strong customer receipts.

 

The audit with BDO LLP is currently underway and Falanx will report its results in September 2021.

 

New Loan Facility to Support Investment

 

The Group is also pleased to announce a five-year Growth Loan facility with BOOST&Co.

 

The key terms are:

 

· Initial £1m loan secured over the Group's assets, expected to increase to £2.5m to fund acquisitions & investment programmes

· Annual interest of 11%, and straight-line amortisation of the loan commencing after 12 months

· The loan carries a 3% early prepayment fee on the then amount outstanding

 

As stated in February 2021, the proceeds of the Loan will enable the Group to make earnings enhancing acquisitions to strengthen its core Cyber division, as well as supporting the Group's overall organic growth plans. This loan was arranged by Welbeck Ventures Limited who received a fee of 2% of the loan on completion in respect of advisory fees. Alex Hambro, the non-executive chairman of Falanx, is also director of Welbeck. 

 

 

 

Joanna Scott, Managing Director at BOOST&Co, said: "We are delighted to be working with Falanx on its continuing growth journey and supporting UK businesses during this uncertain time. Falanx's innovative services, solid customer relationships, growing order book and market alignment combined with a strong management team put the business in a positive position to capitalise on its growth opportunities in the near future."

 

Trading for the year to 31 March 2022

 

Trading for the first four months of the current financial year has been encouraging and is in line with management's expectations.

 

· Order inflow has been good, and this trend is expected to continue

· Gross margins are improving in the Cyber division due to the increased order flow and high staff utilisation levels. Further improvement is expected in the near term as the move to a single Triarii cyber security monitoring platform completes

· This has noticeably improved the financial performance in the Cyber division, which is now profitable at an adjusted EBITDA level, compared with a loss of c£0.52m for the year to 31 March 2021

 

Overall, the Group's current run rate of losses at an adjusted EBITDA level is lower than in 2021 and it continues to focus on becoming sustainably profitable.

 

Cyber Security Division

 

The Company continues to gain new customers for its Triarii cyber security monitoring services and has a strong pipeline of business across several vertical markets. As well as providing an enhanced protective and monitoring service to clients, Triarii is a more efficient and capable platform for operating our Security Operating Centre ("SOC"), leading to greater synergies by operating across a single technology platform.

 

New customers have also benefitted from the inclusion of the Group's new standalone Managed EDR (Endpoint Detection and Response) as an enhanced entry-level protection against ransomware. This allows customers to adopt the much wider capabilities of the Group's Triarii MDR (Managed Detection and Response) service and its "Detection in Depth" approach.

 

The spinout of N-able (formerly SolarWinds MSP) into a separately traded public company, N-able, Inc ("N-able"), completed last month. A key strategy of N-able is to empower and protect its 25,000 MSP customers (and over 500,000 end users) with cybersecurity products and services, and the Company believes that it is very well positioned to address this market. Falanx has already been working closely with N-able to provide Triarii services to its customers and is a member of its Technology Alliance Program. Management is closely engaging with N-able and expects this spinout to benefit Falanx in the second half of 2021 by accelerating sales of its security products and services into their MSP customers and to widen the routes available for increased engagement.

 

The division's sales performance has improved, not only with the initial post COVID-19 rebound, but also from the sale of multi-year contracts. On average the division has received total orders £0.34m per month since 1 July 2020 compared with an average of £0.19m per month in the first six months of 2020. Falanx received its largest ever sales order in April 2021 with a £1m multi-year contract for penetration testing, only the first year of this is reflected in the average order value referred to above. This order was from an existing client, a leading and globally recognised financial services organisation, and management believes that there is a further opportunity for expansion on this account.

 

The pipeline of business continues to strengthen for both assessment and Triarii services, both in terms of quality and quantum. The recent record order intake and healthy orderbook is converting into revenue, driven through optimum utilisation of the highly motivated and expert team.

 

Assynt Strategic Intelligence Division

 

The Assynt business has continued to perform solidly and has achieved strong customer renewals. A £1.2m three-year contract with one of the world's largest technology companies has been further expanded with a requirement for embedded analysts in EU territories. This will be serviced from the Group's newly formed subsidiary in Ireland and is expected to generate revenues of c£1.0m over the next three years. Contracted (adjusted for undelivered contracts and known churn) monthly recurring revenues are currently circa £190,000, marking an increase of 19% since March 2021.

 

Falanx Assynt was recognised by Chambers & Partners in their 2021 rankings, listed as one of five firms in their tier of global Geopolitical Risk providers. Charles Hollis, the Managing Director of Assynt, was also rated among the top five individual practitioners globally.

 

 

 

Mike Read, CEO, commented: "Our much-improved trading, particularly in our core Cyber Security division combined with the new Boost loan puts us in strong position to exploit the major opportunities ahead, either by organic investment or by earnings enhancing acquisitions. I am optimistic about the opportunity with N-Able and its large customer base following the completion of their spin out later this month. This progress in Cyber, and the growing expanding contract base in our Assynt division underpin our plans for growing equity value."

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLTTSIDLIL
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.